Health ❯ Healthcare

Clinical Research

Clinical Trials Patient Outcomes Drug Development Study Findings Efficacy Studies Drug Trials Drug Efficacy Phase 3 Trials Epidemiology Observational Studies

Osun Pilot Links Community Outreach to Early Colorectal Cancer Detection

A pragmatic outreach-plus-navigation model offers a scalable early-detection path in Nigeria's late-presentation context.

Mount Sinai Study Introduces NutriSighT to Predict Underfeeding in Ventilated ICU Patients

Large Swedish Study Finds ARBs Sustain the Best Long-Term Adherence in Hypertension

Stories older than 24h

FDA-Approved AI Tool Shows Promise for Faster Autism Diagnosis in Rural Primary Care

FDA Approves Rybrevant Faspro, a 5‑Minute Subcutaneous Amivantamab for EGFR‑Mutated Lung Cancer

FDA Clears Enhertu-Perjeta Combo for First-Line HER2-Positive Metastatic Breast Cancer

Review: Cutting Saturated Fat Helps High-Risk Patients, Shows Little Gain for Others

Sanofi, Dren Bio Set Autoimmune Collaboration Worth Up to $1.7 Billion With $100 Million Upfront

Gilead’s BIC/LEN HIV Tablet Matches Biktarvy in Phase 3 Switch Trial

Kyverna CAR-T Delivers Positive Phase 2 Topline in Stiff Person Syndrome as Shares Jump

FDA Approves Two First-in-Class Oral Treatments for Gonorrhea

Study Finds No Added Breast Cancer Risk From Menopausal Hormone Therapy in BRCA Carriers

Lancet Phase III Trial Finds Proton Therapy Improves 5-Year Survival in Oropharyngeal Cancer

China Approves Sanofi’s Qfitlia for Hemophilia A Prophylaxis and Cablivi for aTTP

FDA Opens Safety Review of Infant RSV Antibody Drugs Beyfortus and Enflonsia

Tucatinib Added to First-Line HER2 Maintenance Prolongs Progression-Free Survival in Phase 3 Trial

GigaTIME AI Converts Routine H&E Slides Into Virtual Spatial Proteomics at Population Scale

Meta-Analysis Finds GLP-1 Drugs Show Little Short-Term Impact on Obesity-Linked Cancer Risk

Roche’s Giredestrant Cuts Early Breast Cancer Recurrence 30% in Phase III Trial

Teclistamab–Daratumumab Delivers Major Survival Gains in Relapsed Myeloma, Phase 3 Data Show